+ |
PLG | down-regulates activity
cleavage
|
APOH |
0.47 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-266996 |
Lys336 |
HSSLAFWKTDASDVK |
Homo sapiens |
|
pmid |
sentence |
9596664 |
Plasmin can reduce the function of human beta2 glycoprotein I by cleaving domain V into a nicked form| The cleavage site of r-Domain V and beta2GPI by plasmin was proved to be Lys 317-Thr 318 by amino acid sequence analysis of the digest and of the C-terminal peptide isolated by high-performance liquid chromatography. The cleavage was completely inhibited by plasmin inhibitor (alpha2PI). The nicked form was demonstrated to show reduced affinity for CL with a dissociation constant of one order of magnitude larger than that of the intact beta2GPI. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Tissue: |
Blood Plasma |
+ |
F10 | down-regulates activity
cleavage
|
APOH |
0.394 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-266997 |
Lys336 |
HSSLAFWKTDASDVK |
in vitro |
|
pmid |
sentence |
9596664 |
In the previous study, we found that factor Xa can produce the nicked form by cleaving Lys 317-Thr 318, using recombinant human domain V (r-Domain V). |The cleavage was completely inhibited by plasmin inhibitor (alpha2PI). The nicked form was demonstrated to show reduced affinity for CL with a dissociation constant of one order of magnitude larger than that of the intact beta2GPI. |
|
Publications: |
1 |
Organism: |
In Vitro |
+ |
APOH | down-regulates quantity by destabilization
binding
|
cardiolipin |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-266998 |
|
|
Homo sapiens |
|
pmid |
sentence |
9596664 |
The most relevant physiological role of beta2GPI is supposed to be the regulation of the function of anionic phospholipids like cardiolipin (CL). |Anticardiolipin antibodies or lupus anticoagulants are strongly associated with thrombosis. In these autoimmune diseases with anti-phospholipid antibody syndrome, beta2GPI is a cofactor in the recognition of the phospholipid antigen, CL, by anti-CL antibodies. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |